The scientific committee welcomes the submission of scientific abstracts.
There is no restriction on the quantity of abstracts you can submit. However, you are not allowed to present the same study or data set in several formats as stated above. The Scientific Committee will assess all abstracts. The committee has the authority to choose the abstracts that are relevant to the sessions and to determine the final format of presentation.
In order to present their work during the congress, the author who submitted successful abstracts for oral and live presentation must register as a delegate before September 20, 2024.
The Objective and Conclusion need to be consistent with those in the main text and should use the same wording. The results should present the main outcomes of the study using specific numerical data (e.g., absolute numbers and/or rates) with appropriate indicators of statistical uncertainty, such as 95% confidence intervals or p values. P values should never be presented alone without the actual data that are being compared. Do not use reference citations in the abstract. Abbreviations should be minimized and, if used, must be defined within the abstract by full terminology followed by abbreviation in parenthesis.
For medical terms such as proper nouns, generic names of medicines, and units of measurement, use the original term. The use of acronyms and abbreviations is discouraged and should be kept to a minimum. When used, they are to be defined where first used, followed by the acronym or abbreviation in parentheses. Measurements and laboratory values should be in accordance with the International System of Units (SI).
Ensure correct use of the terms sex (when reporting biological factors) and gender (identity, psychosocial or cultural factors), and, unless inappropriate, report the sex or gender of study participants, the sex of animals or cells, and describe the methods used to determine sex or gender. If the study was done involving an exclusive population, for example in only one sex, authors should justify why, except in obvious cases (e.g., prostate cancer). Authors should define how they determined race or ethnicity and justify their relevance.
The names and locations (city and state or country) of manufacturers of equipment and non-generic drugs should be given.
Ensure that all changes, corrections, and proofreading have been carried out before submission.
The organisers of this event take no responsibility for any published abstracts submitted. Any issues or errors arising from the abstracts are solely the responsibility of the authors.By submitting their work, the author(s) give permission for the abstracts to be published, transfer and assign to the Congress the rights to edit, publish, reproduce, distribute copies, and create derivative works such as press releases. The author(s) confirms that they are the only author(s) of the work and that all authors have contributed to and agree with the content and conclusions of the work. Furthermore, the work is original and does not violate any copyright, proprietary, or personal rights of any third party. If the work is not original, the author(s) must acknowledge the original source and confirm that all necessary permissions and authorizations for reuse have been acquired.
If you have any inquiries, kindly direct them to abstractmysir@gmail.com via email.